首页> 外文期刊>Interventional cardiology. >Cutting balloon for the treatment of resistant pulmonic valve stenosis
【24h】

Cutting balloon for the treatment of resistant pulmonic valve stenosis

机译:切割球囊治疗抵抗性肺动脉瓣狭窄

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Congenital pulmonic valve stenosis comprises 7.5-9% of congenital heart defects. The treatment of choice is percutaneous balloon valvuloplasty; however, a small percentage of patients have thick and flexible valve leaflets (dysplastic valves) that require, surgical valvotomy. We aim to report our experience using a cutting balloon and repeated balloon dilation as a last attempt before surgical referral. Methods: Between June 2005 and November 2010, we treated 50 patients with isolated pulmonic valve stenosis. Five patients (10%) had thick and dysplastic pulmonic valve leaf lets that were resistant to repeated balloon dilation attempts. We attempted to create a tear in the dysplastic pulmonic valve by performing pulmonic valvotomy using a cutting balloon (Boston Scientific, Natick, MA, USA), which was advanced through a long sheath, followed by repeated standard balloon dilation. Results: There was no change in the peak systolic gradient at catheterization after conventional pulmonic valve balloon dilation. However, a reduction of 37% was observed, during catheterization, after cutting balloon dilation and additional standard balloon dilation (p = 0.09). Echocardiographic follow-up showed a 23% decrease of the maximum instantaneous gradient early after cutting balloon dilation of the pulmonic valve (from 75 ± 15 to 58 ±4 mmHg, p = 0.05). There was no restenosis of the valve (50 ± 13 mmHg) at long-term 5.5 years ± 9 months follow-up (range 4.5-6 years) and no complications. Conclusion: The use of cutting balloon is a possible option for the treatment of resistant congenital pulmonic valve stenosis before referral for surgical valvotomy. A larger controlled trial is needed to assess the effectiveness and safety of the procedure and validate our experience in this small series.
机译:背景:先天性肺动脉瓣狭窄占先天性心脏缺陷的7.5-9%。选择的治疗方法是经皮球囊瓣膜成形术。然而,一小部分患者需要进行瓣膜切开术,瓣膜小叶厚而有弹性(增生瓣膜)。我们的目的是报告在手术转诊之前使用切割球囊和反复球囊扩张作为最后尝试的经验。方法:2005年6月至2010年11月,我们治疗了50例孤立的肺动脉瓣狭窄患者。五名患者(10%)的肺动脉瓣厚薄且增生异常,可抵抗反复的球囊扩张尝试。我们试图通过使用切开球囊(波士顿科学公司,内蒂克,马萨诸塞州,美国)进行肺动脉瓣切开术,在增生性肺动脉瓣上造成撕裂,该切开球通过长鞘前进,然后重复标准的球囊扩张术。结果:常规肺动脉瓣球囊扩张后,导管插入时的收缩压峰值峰值无变化。但是,在切开球囊扩张和其他标准球囊扩张后,在导管插入过程中观察到减少了37%(p = 0.09)。超声心动图随访显示,切开肺动脉瓣球囊扩张后,最大瞬时梯度降低了23%(从75±15到58±4 mmHg,p = 0.05)。长期5.5年±9个月的随访(范围4.5-6年),无瓣膜再狭窄(50±13 mmHg),无并发症。结论:使用切割球囊可能是治疗性先天性肺动脉瓣狭窄在转诊外科瓣膜切开术之前的一种可能选择。需要进行较大规模的对照试验,以评估该程序的有效性和安全性,并验证我们在这一小系列试验中的经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号